DiscoverKDIGO Conversations in NephrologyEpisode 11: Recent Progress in the Treatment of AAV and its Impact on the Outcome of the Patients
Episode 11: Recent Progress in the Treatment of AAV and its Impact on the Outcome of the Patients

Episode 11: Recent Progress in the Treatment of AAV and its Impact on the Outcome of the Patients

Update: 2023-02-22
Share

Description

In this episode, host Dr. Vladimir Tesar (General University Hospital, Prague) and Dr. David Jayne (Addenbrooke's Hospital, United Kingdom) discuss the roles of various agents in the induction and maintenance treatment of ANCA- associated vasculitis. They will explore the use of rituximab and complement inhibition in treating ANCA-associated vasculitis. This episode will address the gaps in knowledge and ongoing research in the field of ANCA-associated vasculitis.

This episode is supported by Amgen.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 11: Recent Progress in the Treatment of AAV and its Impact on the Outcome of the Patients

Episode 11: Recent Progress in the Treatment of AAV and its Impact on the Outcome of the Patients

KDIGO Communications